Martin J. Joyce's most recent trade in Aldeyra Therapeutics Inc was a trade of 62,728 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 10, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Aldeyra Therapeutics Inc | Martin J. Joyce | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2025 | 62,728 | 62,728 | - | - | Stock Option (Right to Buy) | |
| Aldeyra Therapeutics Inc | Martin J. Joyce | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2025 | 7,238 | 7,238 | - | - | Stock Option (Right to Buy) | |
| Aldeyra Therapeutics Inc | Martin J. Joyce | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2025 | 1,689 | 1,689 | - | - | Stock Option (Right to Buy) | |
| Aldeyra Therapeutics Inc | Martin J. Joyce | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 40,282 | 40,282 | - | - | Stock Option (Right to Buy) | |
| Aldeyra Therapeutics Inc | Martin J. Joyce | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 5,209 | 5,209 | - | - | Stock Option (Right to Buy) | |
| Aldeyra Therapeutics Inc | Martin J. Joyce | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 1,215 | 1,215 | - | - | Stock Option (Right to Buy) | |
| Aldeyra Therapeutics Inc | Martin J. Joyce | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2023 | 21,222 | 21,222 | - | - | Stock Option (Right to Buy) | |
| Aldeyra Therapeutics Inc | Martin J. Joyce | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2023 | 2,744 | 2,744 | - | - | Stock Option (Right to Buy) | |
| Aldeyra Therapeutics Inc | Martin J. Joyce | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2023 | 640 | 640 | - | - | Stock Option (Right to Buy) | |
| Aldeyra Therapeutics Inc | Martin J. Joyce | Director | Purchase of securities on an exchange or from another person at price $ 3.48 per share. | 23 Jun 2022 | 4,323 | 23,967 (0%) | 0% | 3.5 | 15,025 | Common Stock |
| Aldeyra Therapeutics Inc | Martin J. Joyce | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2022 | 53,812 | 53,812 | - | - | Stock Option (Right to Buy) | |
| Aldeyra Therapeutics Inc | Martin J. Joyce | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2022 | 6,958 | 6,958 | - | - | Stock Option (Right to Buy) | |
| Aldeyra Therapeutics Inc | Martin J. Joyce | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2022 | 1,624 | 1,624 | - | - | Stock Option (Right to Buy) | |
| Aldeyra Therapeutics Inc | Martin J. Joyce | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2021 | 13,534 | 13,534 | - | - | Stock Option (Right to Buy) | |
| Aldeyra Therapeutics Inc | Martin J. Joyce | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2021 | 1,750 | 1,750 | - | - | Stock Option (Right to Buy) | |
| Aldeyra Therapeutics Inc | Martin J. Joyce | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2021 | 408 | 408 | - | - | Stock Option (Right to Buy) |